Global population pharmacokinetics of the investigational Aurora A kinase inhibitor alisertib in cancer patients: rationale for lower dosage in Asia
Xiaofei Zhou; Diane R. Mould; Takatoshi Takubo; Emily Sheldon‐Waniga; Dirk Huebner; Ashley Milton; Karthik Venkatakrishnan
Author Information: Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.